+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravenous (IV) Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • PDF Icon

    Report

  • 190 Pages
  • October 2023
  • Region: Global
  • TechSci Research
  • ID: 5893569
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Intravenous (IV) Hydration Therapy Market, valued at USD 3.04 Billion in 2022, is poised for remarkable growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 6.76% and expected to reach USD 4.49 Billion by 2028. Intravenous (IV) Hydration Therapy is a medical treatment involving the direct delivery of fluids, electrolytes, and sometimes medications into a person's bloodstream through a vein. This therapy is commonly utilized to address dehydration and various medical conditions.

Key Market Drivers

1. Increasing Surgical Procedures Drive Market Growth: The growth of the global Intravenous (IV) hydration therapy market is primarily driven by the increasing number of surgical procedures. IV hydration therapy plays a vital role in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. IV hydration therapy ensures that patients are adequately hydrated before surgery, supporting stable blood pressure, optimal organ function, and overall well-being. During surgery, IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's response to surgical stress and anesthesia. After surgery, IV hydration therapy is essential for preventing complications, facilitating the healing process, and reducing the risk of postoperative issues.

2. Wellness and Performance Enhancement Drive Market Growth: The rise of wellness and lifestyle-oriented approaches has significantly contributed to the growth of the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. IV hydration therapy is positioned as a solution to address these needs. It offers a quick and efficient method to rehydrate the body, which is essential for overall well-being and optimal physical performance. Athletes, fitness enthusiasts, and individuals with demanding lifestyles turn to IV hydration therapy to rapidly restore hydration levels, combat fatigue, and replenish essential electrolytes lost during strenuous physical activity. The pursuit of peak physical and cognitive performance has led individuals to explore IV hydration therapy as a means to support their goals. Customizable IV treatments tailored to individual needs further appeal to those seeking personalized solutions for wellness and performance enhancement.

3. Growing Aging Population Propels Market Growth: The increasing aging population is a significant driver of the global Intravenous (IV) hydration therapy market. As people age, their susceptibility to dehydration and electrolyte imbalances rises, making IV hydration therapy an essential medical intervention. Older adults may experience reduced thirst sensation, leading to inadequate fluid intake and an increased risk of dehydration. IV hydration therapy quickly addresses dehydration and helps prevent associated health complications. Chronic conditions, including kidney disease, diabetes, and cardiovascular disorders, become more prevalent with age, often leading to fluid and electrolyte imbalances that require regular IV hydration therapy for symptom management and overall health maintenance. Medical procedures, surgeries, and hospitalizations are also more frequent among older adults, with IV hydration therapy commonly used to manage fluid and electrolyte imbalances resulting from medical interventions. Additionally, older adults frequently take multiple medications that can affect fluid and electrolyte balance, making IV hydration therapy a valuable tool in supporting proper hydration and minimizing medication-related side effects.

Key Market Challenges

1. Regulatory and Legal Considerations: Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market. Ensuring patient safety, maintaining quality standards, and adhering to local and international regulations governing medical practices and the administration of medical treatments are essential. Healthcare providers who administer IV hydration therapy must hold the appropriate licenses and certifications, which can involve extensive training and education. Different jurisdictions have varying requirements, which can affect the availability and accessibility of IV therapy services.

2. Public Perception and Education: Public perception and education present challenges to the global Intravenous (IV) hydration therapy market. Misconceptions and lack of awareness about the appropriate medical indications for IV hydration therapy can hinder its responsible use. The distinction between medical necessity and wellness or lifestyle use of IV hydration therapy can be unclear, leading to overuse, underuse, or misuse of the treatment. Public perception is influenced by the availability of scientific evidence supporting the benefits of IV hydration therapy. Insufficient clinical studies and evidence-based research on certain applications can lead to skepticism or uncertainty.

3. Medical Professional Expertise: Medical professional expertise is a significant challenge to the global Intravenous (IV) hydration therapy market. Administering IV fluids and nutrients safely and effectively requires specialized training and skills. The availability of qualified healthcare practitioners trained in IV therapy can impact the accessibility and quality of IV hydration therapy services. Different healthcare professions have varying scopes of practice and regulations regarding IV therapies, potentially restricting patient access to these treatments. Complex patient cases may require a higher level of expertise to determine appropriate IV therapy protocols.

Key Market Trends

1. Rise of Wellness and Lifestyle Use: A notable trend in the global Intravenous (IV) Hydration Therapy market is the rise of wellness and lifestyle-oriented use. This trend sees individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. IV hydration therapy is perceived as a complementary approach to maintaining overall health, aligning with the growing interest in holistic well-being. Consumers, including athletes and those with demanding lifestyles, turn to IV hydration therapy to boost energy levels, recover from fatigue, and enhance overall vitality. The convenience and rapid results offered by IV hydration therapy appeal to busy individuals seeking immediate revitalization.

2. Customizable Treatments: IV hydration therapy providers are increasingly offering customizable treatments tailored to individual needs and goals. This personalized approach allows patients to adjust the composition of fluids and nutrients based on specific requirements. Customizable IV therapy options align with the trend of individuals seeking tailored solutions for wellness, performance enhancement, and overall well-being. Patients can work with healthcare professionals to design IV treatments that address their unique health and lifestyle objectives.

Segmental Insights

Service Insights: In 2022, the Intravenous (IV) Hydration Therapy market was dominated by energy-boosting treatments, a trend predicted to continue. These treatments provide immediate solutions for fatigue, low energy levels, and vitality. Athletes and individuals with busy lifestyles turn to energy-boosting IV therapy to enhance their performance and quickly replenish essential nutrients. The demand for treatments that promote overall well-being and lifestyle enhancement supports the growth of energy-boosting IV therapy, with the segment projected to experience the highest compound annual growth rate (CAGR) from 2023 to 2030.

Component Insight: In 2022, the Intravenous (IV) Hydration Therapy market was dominated by the medicated segment, expected to continue expanding. Medicated IV hydration therapy is often employed for medical conditions requiring targeted interventions. Patients with severe dehydration, electrolyte imbalances, nutrient deficiencies, or specific acute illnesses benefit from IV therapy with tailored medications

and nutrients. Hospitals and clinical settings commonly use medicated IV therapy as part of standard medical protocols.

End-Use Industry Insights: In 2022, hospitals and clinics dominated the Intravenous (IV) Hydration Therapy market, expected to continue expanding. These healthcare settings provide a controlled and medically supervised environment for IV hydration therapy. Medical professionals, including doctors and nurses, are trained to assess patient needs and administer IV therapy safely. Hospitals and clinics offer comprehensive medical care, allowing IV hydration therapy to be integrated into overall patient treatment plans.

Regional Insights: The Asia Pacific region leads the Global Intravenous (IV) Hydration Therapy Market, with North America, particularly the United States and Canada, also playing a significant role. North America benefits from an advanced healthcare system, well-established healthcare facilities, and a health-conscious population. The prevalence of wellness trends and the pursuit of holistic health and performance optimization contribute to the popularity of IV therapy in this region.

Key Market Players

  • Core IV Therapy, LLC
  • Rejuvenated UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health Inc
  • JW Life Science Corporation
  • Amanta Healthcare Ltd
  • Baxter International Inc.
  • Drip Hydration Inc

Report Scope:

In this report, the Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service:

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others

Intravenous (IV) Hydration Therapy Market, By Component:

  • Medicated
  • Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-User:

  • Hospitals & Clinics
  • Wellness Centers & Spas
  • Home Healthcare
  • Others

Global Intravenous (IV) Hydration Therapy Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

Global Intravenous (IV) Hydration Therapy Market report with the given market data, the publisher offers customizations according to a company's specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Intravenous (IV) Hydration Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
5.2.2. By Component (Medicated, Non-medicated)
5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
5.2.4. By Company (2022)
5.2.5. By Region
5.3. Market Map
6. North America Intravenous (IV) Hydration Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Component
6.2.3. By End-Use Industry
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Component
6.3.1.2.3. By End-Use Industry
6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Component
6.3.2.2.3. By End-Use Industry
6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Component
6.3.3.2.3. By End-Use Industry
7. Europe Intravenous (IV) Hydration Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Component
7.2.3. By End-Use Industry
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Component
7.3.1.2.3. By End-Use Industry
7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Component
7.3.2.2.3. By End-Use Industry
7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Component
7.3.3.2.3. By End-Use Industry
7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Component
7.3.4.2.3. By End-Use Industry
7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Component
7.3.5.2.3. By End-Use Industry
8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Component
8.2.3. By End-Use Industry
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Component
8.3.1.2.3. By End-Use Industry
8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Component
8.3.2.2.3. By End-Use Industry
8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Component
8.3.3.2.3. By End-Use Industry
8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Component
8.3.4.2.3. By End-Use Industry
8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Component
8.3.5.2.3. By End-Use Industry
9. South America Intravenous (IV) Hydration Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Component
9.2.3. By End-Use Industry
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Component
9.3.1.2.3. By End-Use Industry
9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Component
9.3.2.2.3. By End-Use Industry
9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Component
9.3.3.2.3. By End-Use Industry
10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Component
10.2.3. By End-Use Industry
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Component
10.3.1.2.3. By End-Use Industry
10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Component
10.3.2.2.3. By End-Use Industry
10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Component
10.3.3.2.3. By End-Use Industry
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. Competitive Landscape
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (In case of listed companies)
15.5. Recent Developments
15.6. SWOT Analysis
15.6.1. Core IV Therapy, LLC
15.6.2. Cryojuvenate UK Ltd.
15.6.3. B. Braun Medical Inc.
15.6.4. Otsuka Pharmaceutical Co., Ltd.
15.6.5. NexGen Health Inc
15.6.6. JW Life Science Corporation
15.6.7. Amanta Healthcare Ltd
15.6.8. Baxter International Inc.
15.6.9. Drip Hydration Inc
16. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health Inc
  • JW Life Science Corporation
  • Amanta Healthcare Ltd
  • Baxter International Inc.
  • Drip Hydration Inc

Table Information